CERVOMED INC. - COMMON STOCK

9,6000

22-ноября-24 15:44:58

15 мин. задержка

Акции

+0,0200

+0,21%

Сегодняшний диапазон

9,3000 - 10,3000

ISIN

N/A

Источник

NASDAQ

CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

01 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in Upcoming Investor Conferences

28 мар 2024 15:05:00 Источник Nasdaq GlobeNewswire
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors

28 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024

05 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in the BIO CEO and Investor Conference

21 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies

12 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board

07 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in the Emerging Growth Conference 67

05 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in the Emerging Growth Conference 66

05 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.